| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 09/28/2005 | CN1675201A N-substituted piperidine derivatives as serotonin receptor agents |
| 09/28/2005 | CN1675198A Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
| 09/28/2005 | CN1675185A Therapeutic molecules and methods-1 |
| 09/28/2005 | CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 09/28/2005 | CN1674927A Growth hormone releasing peptides |
| 09/28/2005 | CN1674914A Female hormone-containing patch |
| 09/28/2005 | CN1674912A Methods of treatment of male erectile dysfunction |
| 09/28/2005 | CN1674907A Use of reboxetine for the treatment of hot flashes |
| 09/28/2005 | CN1674895A Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/28/2005 | CN1674880A Agonism of the 5HT2a receptor for treatment of thermoregulatory dysfunction |
| 09/28/2005 | CN1674879A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 09/28/2005 | CN1674866A New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
| 09/28/2005 | CN1674795A Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 09/28/2005 | CN1672732A Stable recombinant solid alpha-interferon composition |
| 09/28/2005 | CN1672725A Medicine for resisting inflammation, contracting uterus and eliminating tumor and its prepn process |
| 09/28/2005 | CN1672724A Diuretic and menstruation-regulating medicine and its prepn |
| 09/28/2005 | CN1672723A Medicine for treating climacteric syndrome and preparing method thereof |
| 09/28/2005 | CN1672707A Cervicitis resisting dispersive tablet and its prepn |
| 09/28/2005 | CN1672704A Erosion-eliminating effervescent tablet and its prepn |
| 09/28/2005 | CN1672701A Chinese medicine capsule for treating women's dysmenorrhea |
| 09/28/2005 | CN1672689A Nano silver antiseptic gel for treating women's genital tract infection and its prepn and application |
| 09/28/2005 | CN1672685A New contraception medicine |
| 09/28/2005 | CN1672679A Application of externally applied phentolamine methane sulphonate prepn in treating female sexual apathy |
| 09/28/2005 | CN1220696C 16 alpha-methyl or ethyl substituted estrogens |
| 09/28/2005 | CN1220514C Preparation of Chinese patent medicine for treating hyperplasia of mammary glands |
| 09/28/2005 | CN1220500C Skin Chinese medicine disinfectant liquid and use in preparing medicine for suppressing prospermia |
| 09/28/2005 | CN1220499C Kidney-invigorating and Yang-strengthening wine |
| 09/28/2005 | CN1220491C Non-oral androgenic steroids used in preparation of medicine for improvement of raising sex hormones combined globulin level |
| 09/27/2005 | US6949579 Central nervous system disorders; antidiabetic agents |
| 09/27/2005 | US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 09/27/2005 | US6949547 Antidiabetic agents; central nervous system disorders; cardiovascular disorders; hypotensive agents; anticancer agents |
| 09/27/2005 | US6949541 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof |
| 09/27/2005 | US6949531 14 β, 16, 17-methylene steroids as novel androgens |
| 09/27/2005 | US6949526 Erectile dysfunction remedies containing prostaglandin derivatives as the active ingredient |
| 09/27/2005 | US6949510 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 09/27/2005 | CA2356747C Triphasic oral contraceptive |
| 09/23/2005 | CA2502169A1 Products and methods for treating vaginal infections |
| 09/22/2005 | WO2005087775A1 Tricyclic heterocyclic compound and medicinal composition containing the compound as active ingredient |
| 09/22/2005 | WO2005025503A3 A composition and method of treatment for urogenital conditions |
| 09/22/2005 | US20050209341 R-(-)-N-methyl 3-((2-methyl-4-hydroxyphenyl)oxy)-3-phenyl-1-aminopropane or its hydrochloride salt; inhibiting the uptake of norepinephrine and serotonin; antidepressants, analgesics; treating sleep disorders, autism, psychological disorders, eating disorders |
| 09/22/2005 | US20050209338 Phenethanolamine derivatives for treatment of respiratory diseases |
| 09/22/2005 | US20050209329 Potentiation of therapeutic effects of fatty acids |
| 09/22/2005 | US20050209261 Rho-kinase inhibitors |
| 09/22/2005 | US20050209252 Using an indazole compound |
| 09/22/2005 | US20050209243 7-[2-[4-(2-methoxyphenyl)piperazinyl]-ethyl]-1,3-dimethylxanthine (KMUP-1); muscle relaxants, endothelium-dependent NO releasing, learning and memory activities, erectile dysfunction |
| 09/22/2005 | US20050208494 Novel proteins and dnas thereof |
| 09/22/2005 | US20050208158 nutraceutic mixture comprising plant extract of steroid saponins and bio-active zinc, bio-active selenium; treating HIV, herpes virus; antiinflammatory agent treating veins, capillaries, kidneys, bladder, and prostate gland; increasing good cholesterol concentration; strengthening immune system |
| 09/22/2005 | US20050208081 With water miscible solubilizer; phosphodiesterase inhibitors; cardiovascular disorders |
| 09/21/2005 | EP1577387A1 Preventives/remedies for cancer |
| 09/21/2005 | EP1577323A1 Metastin derivative and use thereof |
| 09/21/2005 | EP1577288A1 Selective estrogen receptor modulators |
| 09/21/2005 | EP1576964A1 Protease inhibitor |
| 09/21/2005 | EP1576893A1 Composition containing isoflavone of high purity at high concentration and process for producing the same |
| 09/21/2005 | EP1575942A1 Novel compounds having selective inhibiting efect at gsk3 |
| 09/21/2005 | EP1575939A1 Novel compounds having selective inhibiting effect at gsk3 |
| 09/21/2005 | EP1575938A1 Novel compounds having selective inhibiting effect at gsk3 |
| 09/21/2005 | EP1575916A2 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain |
| 09/21/2005 | EP1575607A1 Vanilloid receptor-2 ligands for treating anxiety or depression |
| 09/21/2005 | EP1575589A1 Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives |
| 09/21/2005 | EP1575521A2 Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof |
| 09/21/2005 | EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 09/21/2005 | EP1220857B1 Gonadotropin releasing hormone receptor antagonists and their related methods of use |
| 09/21/2005 | EP1140091B1 Formulations comprising imiquimod or other immune response modifiers for treating cervical dysplasia |
| 09/21/2005 | EP1042325B1 Nitrogen-containing heterocyclic compounds, their production and use |
| 09/21/2005 | CN1671863A Central airway administration for systemic delivery of therapeutics |
| 09/21/2005 | CN1671730A Oligonucleotide-containing pharmacological compositions and their use |
| 09/21/2005 | CN1671714A Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/21/2005 | CN1671711A Calcitonin gene related peptide receptor antagonists |
| 09/21/2005 | CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof |
| 09/21/2005 | CN1671700A Substituted alkylamine derivatives and methods of use |
| 09/21/2005 | CN1671666A Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines |
| 09/21/2005 | CN1671650A Crystalline beta2 adrenergic receptor agonist |
| 09/21/2005 | CN1671643A Bipolar trans carotenoid salts and their uses |
| 09/21/2005 | CN1671639A Novel biphenyl and biphenyl-like cannabinoids |
| 09/21/2005 | CN1671421A Inclusion complexes of rosiglitazone |
| 09/21/2005 | CN1671398A Compositions and methods for treating epithelia and retinal tissue diseases |
| 09/21/2005 | CN1671394A Composition containing an androgenous 11beta-halogen steroid and a progestational hormone, and male contraceptive based on said composition |
| 09/21/2005 | CN1671390A Adenosine A2A receptor antagonists for treating restless legs syndrome or related disorders |
| 09/21/2005 | CN1671388A Sustained-release tablet composition comprising a dopamine receptor agonist |
| 09/21/2005 | CN1219547C Medicinal composition for treating gynecopathies |
| 09/21/2005 | CN1219544C Capsule for fortifying kidney and nourishing qi and its preparation method |
| 09/21/2005 | CN1219532C Chinese herbal medicine for treating gynecology disease and its preparing method |
| 09/21/2005 | CN1219525C Chinese medicine for treating women's ovary cancer and uterine myoma |
| 09/20/2005 | US6946579 3-carbocycle carbonyl-3-phenylpropionaldehyde intermediates and preparation by alkylating a carbocycle benzyl ketone with an allyl halide and oxidizing the product |
| 09/20/2005 | US6946558 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 09/20/2005 | US6946548 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs. |
| 09/20/2005 | US6946454 Thio-oxindole derivatives |
| 09/20/2005 | US6946275 Human testis specific serine/threonine kinase 1 and 2 |
| 09/20/2005 | US6946244 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 09/20/2005 | US6946141 As-needed administration of tricyclic and other non-SRI antidepressant drugs to treat premature ejaculation |
| 09/20/2005 | CA2170606C Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas |
| 09/15/2005 | WO2005085200A1 Pyridone derivative |
| 09/15/2005 | WO2003000844A3 Protein modification and maintenance molecules |
| 09/15/2005 | US20050203126 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia |
| 09/15/2005 | US20050203079 Serotonin (5-HT) 2c receptors; antidepressants, anxiolytic agents; 3-(3,4-Dichloro-phenyl)-3-hydroxy-1-[4-methoxy-3-(2-piperidin-1-yl-ethoxy)-phenyl]-pyrrolidin-2-one for example |
| 09/15/2005 | US20050203055 Administering an effective amount of a sulfated polysaccharide for therapy and prophylaxis of fungal infection |
| 09/15/2005 | US20050202018 Binding agent, conjugated to a keyhole limpet hemocyanin, that specifically binds to circulating prostate specific antigen and induces a therapeutic immune response |
| 09/15/2005 | US20050202008 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 09/14/2005 | EP1574578A1 Monomeric protein of the TGF-beta family |
| 09/14/2005 | EP1574212A1 Prevention and treatment of androgen-deprivation induced hot flashes, decreased lean muscle mass, loss of libido or erectile dysfunction |